News from oncogenex pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 16, 2014, 06:30 ET
Aug 21, 2014, 16:01 ET

OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small...

Aug 07, 2014, 16:01 ET

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2014

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and announced second quarter 2014 financial...

Aug 07, 2014, 06:30 ET

OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced the appointment of John A. Bencich as Vice President and Chief Financial...

Jul 24, 2014, 06:30 ET

OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2014 financial results will be released on...

Jul 01, 2014, 06:30 ET

OncoGenex Announces Cedar™ Clinical Trial Evaluating Apatorsen in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer is Now Open for Enrollment

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced initiation of the Cedar™ clinical trial, an investigator-sponsored,...

Jun 26, 2014, 18:00 ET

OncoGenex Pharmaceuticals Announces Pricing of $24 Million Underwritten Registered Direct Offering

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that it has priced an underwritten registered direct offering, which is expected to...

Apr 30, 2014, 16:00 ET

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2014

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and anticipated near-term milestones and...

Apr 28, 2014, 07:15 ET

OncoGenex to Report Financial Results for First Quarter 2014 on April 30, 2014

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's first quarter 2014 financial results will be released on...

Apr 28, 2014, 07:10 ET

OncoGenex Announces Top-Line Survival Results of Phase 3 SYNERGY Trial Evaluating Custirsen for Metastatic Castrate-Resistant Prostate Cancer

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced results from the Phase 3 SYNERGY trial. Top-line survival results indicate that the...

Apr 23, 2014, 06:00 ET
Mar 11, 2014, 16:00 ET

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2013

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and anticipated near-term milestones and...

Feb 25, 2014, 06:30 ET

OncoGenex to Report Financial Results for Fourth Quarter and Year-Ended 2013 on March 11, 2014

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and year-ended 2013 financial results will be...

Feb 11, 2014, 06:00 ET

OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Prostate Cancer

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the pre-specified number of events required for final analysis of the...

Feb 06, 2014, 06:30 ET

OncoGenex to Present at Leerink Global Healthcare Investor Conference

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a...

Nov 19, 2013, 06:30 ET

OncoGenex Announces Update on Phase 3 SYNERGY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the SYNERGY trial is continuing as planned per the recommendation of the...

Nov 07, 2013, 16:00 ET

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2013 and Addresses Key Questions from Investors on Quarterly Conference Call

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced third quarter 2013 financial results and will address frequently asked...

Nov 05, 2013, 06:30 ET

OncoGenex to Present at Credit Suisse Healthcare Investor Conference

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a...

Oct 30, 2013, 06:30 ET

OncoGenex to Report Financial Results for Third Quarter 2013 and Address Key Questions from Investors on November 7, 2013

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's third quarter 2013 financial results will be released on...

Aug 27, 2013, 06:30 ET